• Regulatory NewsRegulatory News

    FDA Warns Four Companies Selling Cannabidiol Over Unproven Claims

    The US Food and Drug Administration (FDA) on Wednesday warned four companies selling cannabidiol (CBD) containing products for making claims that their products can treat or cure cancer and other diseases, including Alzheimer's, arthritis, heart disease and stroke. "Selling these unapproved products with unsubstantiated therapeutic claims is not only a violation of the Federal Food, Drug and Cosmetic Act , but also can put patients at risk as these products have not bee...
  • Regulatory NewsRegulatory News

    UK’s MHRA: Products Containing Cannabis Extract are Medicines

    The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has recently come to the decision that products containing cannabidiol (CBD) are a medicine, following a regulatory review of such products. “We have come to the opinion that products containing cannabidiol (CBD) are a medicine. Products for therapeutic use must have a medicines’ licence before they can be legally sold, supplied or advertised in the UK. Products will have to meet safety, quality a...
  • Regulatory NewsRegulatory News

    DEA to Allow Huge Increase in Marijuana Production to Meet Research Demands

    The US Drug Enforcement Administration (DEA) has proposed a massive increase in the amount of marijuana it will allow to be produced this year in the hopes of meeting the demand of researchers studying new medicinal uses for the drug, it has announced. Background In the US, the manufacture and production of marijuana is controlled by the DEA, whose authority to do so stems from the Controlled Substances Act (CSA) —a law which categorizes drugs in accordance with their ...
  • Regulatory NewsRegulatory News

    DEA to Increase Marijuana Production Quota to Meet Demand of Medical Researchers

    The US Drug Enforcement Administration (DEA) is proposing to more than triple the amount of marijuana it will allow to be produced this year in the hopes of meeting the demand of researchers studying new medicinal uses for the drug, it has announced. Background In the US, the manufacture and production of marijuana is controlled by the DEA, whose authority to do so stems from the Controlled Substances Act (CSA) —a law which categorizes drugs in accordance with their ri...